1. Home
  2. ICLR vs HSIC Comparison

ICLR vs HSIC Comparison

Compare ICLR & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$113.35

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Henry Schein Inc.

HSIC

Henry Schein Inc.

HOLD

Current Price

$72.55

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICLR
HSIC
Founded
1990
1932
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.3B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
ICLR
HSIC
Price
$113.35
$72.55
Analyst Decision
Buy
Buy
Analyst Count
13
16
Target Price
$178.62
$85.07
AVG Volume (30 Days)
1.3M
998.5K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.21
EPS
N/A
3.27
Revenue
N/A
$13,201,995,000.00
Revenue This Year
N/A
$6.12
Revenue Next Year
N/A
$3.64
P/E Ratio
$12.91
$22.14
Revenue Growth
N/A
5.94
52 Week Low
$66.57
$61.97
52 Week High
$211.00
$89.29

Technical Indicators

Market Signals
Indicator
ICLR
HSIC
Relative Strength Index (RSI) 52.69 35.53
Support Level $99.11 $70.97
Resistance Level $116.85 $74.96
Average True Range (ATR) 5.40 1.94
MACD 0.33 -0.62
Stochastic Oscillator 64.88 20.56

Price Performance

Historical Comparison
ICLR
HSIC

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.

Share on Social Networks: